価格表

在庫・価格 : 2024年04月28日 04時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
ELISpot Blue Color Module
データシート※最新のデータシートでない場合があります
SEL002 RSDアールアンドディー システムス
R&D Systems, Inc.
1 set ¥35,000
(未発注)
追加

在庫・価格 : 2024年04月28日 04時43分 現在

ELISpot Blue Color Module

  • 商品コード:SEL002
  • メーカー:RSD
  • 包装:1set
  • 価格: ¥35,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Chattergoon MA et al. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 2004 Apr;22(13-14):1744-50
Chattergoon MA et al
2004/01/01
Sample Type: Whole Cells PubMed
2 Kutzler MA et al. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine 2006 May;24(21):4630-9
Kutzler MA et al
2006/01/01
Species: Mouse, Sample type: Whole Cells PubMed
3 Kumar S et al. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine 2006 Mar;24(14):2585-93
Kumar S et al
2006/01/01
Sample Type: Whole Cells PubMed
4 Huleatt JW et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007 Jan;25(4):763-75
Huleatt JW et al
2007/01/01
Sample Type: Whole Cells PubMed
5 Chattergoon MA et al. DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo. Mol. Ther. 2008 Feb;16(2):419-26
Chattergoon MA et al
2008/01/01
Species: Mouse, Application: Whole Cells PubMed
6 Alisa A et al. Human CD4(+) T cells recognize an epitope within alpha-fetoprotein sequence and develop into TGF-beta-producing CD4(+) T cells. J. Immunol. 2008 Apr;180(7):5109-17
Alisa A et al
2008/01/01
Species: Human, Application: Whole Cells PubMed
7 Muthumani K et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008 Sep;26(40):5128-34
Muthumani K et al
2008/01/01
Sample Type: Whole Cells PubMed
8 Moir S et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008 Aug;205(8):1797-805
Moir S et al
2008/01/01
PubMed
9 Cao O et al. Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. Mol. Ther. 2009 Oct;17(10):1733-42
Cao O et al
2009/01/01
Sample Type: Whole Cells PubMed
10 Ghulam Muhammad AK et al. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin. Cancer Res. 2009 Oct;15(19):6113-27
Ghulam Muhammad AK et al
2009/01/01
Sample Type: Whole Cells PubMed
11 Wang Z et al. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. Mol. Ther. 2010 Mar;18(3):617-24
Wang Z et al
2010/01/01
Sample Type: Whole Cells PubMed
12 Jorquera PA et al. Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease. PLoS ONE 2013;8(9):e74905
Jorquera PA et al
2013/01/01
Sample Type: whole cells PubMed
13 Franzoni G et al. Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression. PLoS ONE 2013;8(12):e84246
Franzoni G et al
2013/01/01
Sample Type: Cell Lysates PubMed
14 Muthumani K et al. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo. PLoS ONE 2013;8(12):e84234
Muthumani K et al
2013/01/01
Sample Type: Whole Cells PubMed
15 Martin V et al. The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish®) remains effective against an experimental challenge one year later. Vet. Res. 2014;45:69
Martin V et al
2014/01/01
Sample Type: Whole Cells PubMed
16 Chen D et al. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis. J. Immunol. 2016 Feb;196(4):1541-9
Chen D et al
2016/01/01
Sample Type: Whole Cells PubMed
17 Nakatsugawa M et al. CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep 2016 Mar;6:23821
Nakatsugawa M et al
2016/01/01
Sample Type: Whole Cells PubMed
18 Miyairi S et al. Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance. Eur. J. Immunol. 2017 Apr;47(4):734-742
Miyairi S et al
2017/01/01
Sample Type: Whole Cells PubMed
19 Lee H et al. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection. Sci Rep 2017 Mar;7:43531
Lee H et al
2017/01/01
Sample Type: Whole Cells PubMed
20 Velazquez VM et al. Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting. Mol Ther Methods Clin Dev 2017 Mar;4:159-168
Velazquez VM et al
2017/01/01
Sample Type: Whole Cells PubMed
21 Nemmar A et al. Cerium Oxide Nanoparticles in Lung Acutely Induce Oxidative Stress, Inflammation, and DNA Damage in Various Organs of Mice. Oxid Med Cell Longev 2017;2017:9639035
Nemmar A et al
2017/01/01
Sample Type: Tissue Homogenates PubMed
22 De Palma R et al. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. Cancer Res. 2004 Nov;64(21):8068-76
De Palma R et al
2004/01/01
Species: Mouse PubMed
23 Thampy LK et al. Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration. PLoS ONE 2018;13(6):e0199497
Thampy LK et al
2018/01/01
Species: Human PubMed
24 Kraynyak KA et al. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum. Gene Ther. 2009 Oct;20(10):1143-56
Kraynyak KA et al
2009/01/01
Species: Mouse PubMed
25 Choi H et al. Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS Negl Trop Dis 2019 02;13(2):e0007042
Choi H et al
2019/01/01
PubMed
26 Kraynyak KA et al. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 2010 Feb;28(8):1942-51
Kraynyak KA et al
2010/01/01
PubMed
27 Lieberman R et al. Rad52 deficiency decreases development of lung squamous cell carcinomas by enhancing immuno-surveillance. Oncotarget 2017 May;8(21):34032-34044
Lieberman R et al
2017/01/01
PubMed
28 De Groot AS et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005 Mar;23(17-18):2121-31
De Groot AS et al
2005/01/01
PubMed
29 Schultheis K et al. Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine 2017 01;35(1):61-70
Schultheis K et al
2017/01/01
PubMed
30 Ram鱈rez M et al. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA. Vaccine 2018 04;36(15):2049-2055
Ram鱈rez M et al
2018/01/01
PubMed
31 Khoshnejad M et al. Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity <i>In&#xA0;Vivo</i>. Mol Ther Methods Clin Dev 2020 Sep;18:652-663
Khoshnejad M et al
2020/01/01
Species: Mouse PubMed
32 Tourlomousis P et al. Modifying bacterial flagellin to evade Nod-like Receptor CARD 4 recognition enhances protective immunity against Salmonella. Nat Microbiol 2020 12;5(12):1588-1597
Tourlomousis P et al
2020/01/01
Species: Mouse PubMed
  • No.: 1
  • 文献情報:
    Chattergoon MA et al. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 2004 Apr;22(13-14):1744-50
    Chattergoon MA et al
    2004/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Kutzler MA et al. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice. Vaccine 2006 May;24(21):4630-9
    Kutzler MA et al
    2006/01/01
  • 備考:
    Species: Mouse, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kumar S et al. Development of a candidate DNA/MVA HIV-1 subtype C vaccine for India. Vaccine 2006 Mar;24(14):2585-93
    Kumar S et al
    2006/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Huleatt JW et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. Vaccine 2007 Jan;25(4):763-75
    Huleatt JW et al
    2007/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Chattergoon MA et al. DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo. Mol. Ther. 2008 Feb;16(2):419-26
    Chattergoon MA et al
    2008/01/01
  • 備考:
    Species: Mouse, Application: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Alisa A et al. Human CD4(+) T cells recognize an epitope within alpha-fetoprotein sequence and develop into TGF-beta-producing CD4(+) T cells. J. Immunol. 2008 Apr;180(7):5109-17
    Alisa A et al
    2008/01/01
  • 備考:
    Species: Human, Application: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Muthumani K et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008 Sep;26(40):5128-34
    Muthumani K et al
    2008/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Moir S et al. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals. J. Exp. Med. 2008 Aug;205(8):1797-805
    Moir S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cao O et al. Impact of the underlying mutation and the route of vector administration on immune responses to factor IX in gene therapy for hemophilia B. Mol. Ther. 2009 Oct;17(10):1733-42
    Cao O et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ghulam Muhammad AK et al. Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression. Clin. Cancer Res. 2009 Oct;15(19):6113-27
    Ghulam Muhammad AK et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Wang Z et al. Immune responses to AAV in canine muscle monitored by cellular assays and noninvasive imaging. Mol. Ther. 2010 Mar;18(3):617-24
    Wang Z et al
    2010/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Jorquera PA et al. Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease. PLoS ONE 2013;8(9):e74905
    Jorquera PA et al
    2013/01/01
  • 備考:
    Sample Type: whole cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Franzoni G et al. Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression. PLoS ONE 2013;8(12):e84246
    Franzoni G et al
    2013/01/01
  • 備考:
    Sample Type: Cell Lysates
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Muthumani K et al. HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo. PLoS ONE 2013;8(12):e84234
    Muthumani K et al
    2013/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Martin V et al. The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish&#xAE;) remains effective against an experimental challenge one year later. Vet. Res. 2014;45:69
    Martin V et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Chen D et al. Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis. J. Immunol. 2016 Feb;196(4):1541-9
    Chen D et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Nakatsugawa M et al. CD4(+) and CD8(+) TCR&#x3B2; repertoires possess different potentials to generate extraordinarily high-avidity T cells. Sci Rep 2016 Mar;6:23821
    Nakatsugawa M et al
    2016/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Miyairi S et al. Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance. Eur. J. Immunol. 2017 Apr;47(4):734-742
    Miyairi S et al
    2017/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Lee H et al. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection. Sci Rep 2017 Mar;7:43531
    Lee H et al
    2017/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Velazquez VM et al. Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting. Mol Ther Methods Clin Dev 2017 Mar;4:159-168
    Velazquez VM et al
    2017/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Nemmar A et al. Cerium Oxide Nanoparticles in Lung Acutely Induce Oxidative Stress, Inflammation, and DNA Damage in Various Organs of Mice. Oxid Med Cell Longev 2017;2017:9639035
    Nemmar A et al
    2017/01/01
  • 備考:
    Sample Type: Tissue Homogenates
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    De Palma R et al. Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes. Cancer Res. 2004 Nov;64(21):8068-76
    De Palma R et al
    2004/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Thampy LK et al. Restoration of T Cell function in multi-drug resistant bacterial sepsis after interleukin-7, anti-PD-L1, and OX-40 administration. PLoS ONE 2018;13(6):e0199497
    Thampy LK et al
    2018/01/01
  • 備考:
    Species: Human
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Kraynyak KA et al. Plasmid-encoded interleukin-15 receptor alpha enhances specific immune responses induced by a DNA vaccine in vivo. Hum. Gene Ther. 2009 Oct;20(10):1143-56
    Kraynyak KA et al
    2009/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Choi H et al. Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS Negl Trop Dis 2019 02;13(2):e0007042
    Choi H et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Kraynyak KA et al. Systemic immunization with CCL27/CTACK modulates immune responses at mucosal sites in mice and macaques. Vaccine 2010 Feb;28(8):1942-51
    Kraynyak KA et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Lieberman R et al. Rad52 deficiency decreases development of lung squamous cell carcinomas by enhancing immuno-surveillance. Oncotarget 2017 May;8(21):34032-34044
    Lieberman R et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    De Groot AS et al. Developing an epitope-driven tuberculosis (TB) vaccine. Vaccine 2005 Mar;23(17-18):2121-31
    De Groot AS et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Schultheis K et al. Characterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin. Vaccine 2017 01;35(1):61-70
    Schultheis K et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Ram鱈rez M et al. Characterization of the immune response elicited by the vaccinia virus L3 protein delivered as naked DNA. Vaccine 2018 04;36(15):2049-2055
    Ram鱈rez M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Khoshnejad M et al. Synthetic DNA Delivery of an Engineered Arginase Enzyme Can Modulate Specific Immunity <i>In&#xA0;Vivo</i>. Mol Ther Methods Clin Dev 2020 Sep;18:652-663
    Khoshnejad M et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Tourlomousis P et al. Modifying bacterial flagellin to evade Nod-like Receptor CARD 4 recognition enhances protective immunity against Salmonella. Nat Microbiol 2020 12;5(12):1588-1597
    Tourlomousis P et al
    2020/01/01
  • 備考:
    Species: Mouse
  • 参照:
    PubMed